| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $52.1M | +44.1% |
| SG&A Expense | $41.7M | +38.4% |
| Operating Income | -$93.9M | -41.5% |
| Interest Expense | $700K | — |
| Pre-tax Income | -$95.7M | -68.6% |
| Net Income | -$95.7M | -68.6% |
| EPS (Basic) | -$2.44 | -32.6% |
| EPS (Diluted) | -$2.44 | -32.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $99.7M | -29.9% |
| Current Assets | $103.9M | -28.9% |
| Total Assets | $124.5M | -26.7% |
| Current Liabilities | $32.2M | +80.2% |
| Long-term Debt | $14.1M | — |
| Total Liabilities | $46.4M | +143.3% |
| Stockholders' Equity | $78.1M | -48.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.4M | -28.4% |
| Financing Cash Flow | $21.8M | -63.0% |